WHO strongly recommends antiviral
WHO strongly recommends antiviral drug for patients with non-severe covid-19: A combination of nirmatrelvir and ritonavir is strongly recommended for…
molnupiravir
WHO: Covid-19 antiviral drug molnupiravir recommendation
WHO recommends antiviral drug for patients with non-severe covid-19 at highest risk of hospital admission: The antiviral drug molnupiravir is…
Merck and Ridgeback’s Antiviral Molnupiravir trial
News Release: Merck and Ridgeback’s Investigational Oral Antiviral Molnupiravir Reduced the Risk of Hospitalization or Death by Approximately 50 Percent…